These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Report of a case: gold-associated pulmonary injury. Limpisvasti P; Jones P Hawaii Med J; 1979 Feb; 38(2):43-5. PubMed ID: 108235 [No Abstract] [Full Text] [Related]
4. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis. Edelman J; Davis P; Owen ET J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary damage associated with gold therapy. A report of two cases. Terho EO; Torkko M; Valta R Scand J Respir Dis; 1979 Dec; 60(6):345-9. PubMed ID: 120005 [TBL] [Abstract][Full Text] [Related]
6. [Chrysotherapy and side effects (author's transl)]. Eberl R Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096 [No Abstract] [Full Text] [Related]
12. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin. Tumiati B; Veneziani M; Bellelli A; Portioli I J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794 [No Abstract] [Full Text] [Related]
13. Gold therapy for rheumatoid arthritis. Spruck M Am J Nurs; 1979 Jul; 79(7):1246-8. PubMed ID: 156500 [No Abstract] [Full Text] [Related]
14. Gold therapy in rheumatoid arthritis. Schorn D; Anderson IF S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934 [TBL] [Abstract][Full Text] [Related]